616 Participants Needed

Bridging the Gap Intervention for Violent Injury

NT
NT
Overseen ByNicholas Thomson, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Virginia Commonwealth University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this research study is to find out if a hospital-based violence intervention (Bridging the Gap) is effective for reducing violence. The researchers think that adults who receive Bridging the Gap will see greater improvements than those who do not receive the intervention. This study will allow them to learn more about the intervention's effectiveness. The study will also help them understand if the violence intervention affects other behaviors, such as firearm use, drug use, aggression, risky behaviors, and rates of violent re-injury.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Bridging the Gap for violent injury?

Research on hospital-based violence intervention programs (HVIPs) shows they can help reduce future injuries and improve mental health and emotional well-being for victims of violence. These programs use a community-based approach to break the cycle of violence and have shown potential in reducing repeat injuries.12345

How is the Bridging the Gap treatment different from other treatments for violent injury?

Bridging the Gap is unique because it is a hospital-based violence intervention program that not only addresses the immediate medical needs of victims of violent injury but also connects them to community resources and support services to prevent future violence. Unlike traditional treatments that focus solely on physical recovery, this program aims to reduce trauma recidivism by providing comprehensive support during and after the hospital stay.36789

Research Team

NT

Nicholas Thomson, PhD

Principal Investigator

Virginia Commonwealth University

Eligibility Criteria

This trial is for English-speaking adults over 18 who live in Richmond City or nearby counties and are treated at the hospital for injuries from violence like gunshot wounds. It's not open to minors, non-English speakers, or prisoners.

Inclusion Criteria

I am being treated in the hospital for an injury caused by violence.
I am 18 years old or older.
They are eligible for BTG services (which includes living within the BTG catchment area for the hospital; Richmond City and neighboring counties)
See 1 more

Exclusion Criteria

I am under 18 years old.
Prisoners
I do not speak English.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

In-hospital Intervention

Participants receive a hospital-based violence prevention program and firearm counseling

During hospital stay
1 visit (in-person)

Community Case Management

Participants receive 6 months of community case management services

6 months

Follow-up

Participants are monitored for outcomes related to firearm-related violence, re-injury, and mortality

12 months
2 follow-up assessments at 6 and 12 months

Treatment Details

Interventions

  • Bridging the Gap
Trial OverviewThe study tests 'Bridging the Gap,' a hospital-based program aimed at reducing retaliatory gun violence among violently injured adults. Researchers will compare outcomes of participants with and without this intervention.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: In-hospital interventionExperimental Treatment1 Intervention
Adults randomized to Bridging the Gap (BTG) services will receive a hospital-based violence prevention program with 6-months of community case management and a firearm counseling program.
Group II: Treatment as usualActive Control1 Intervention
Adults who will not receive BTG services and will receive treatment as usual (TAU) in the hospital.

Bridging the Gap is already approved in United States for the following indications:

🇺🇸
Approved in United States as Bridging the Gap for:
  • Violence prevention
  • Reducing retaliatory gun violence
  • Firearm use reduction
  • Drug use reduction
  • Aggression reduction
  • Risky behavior reduction
  • Violent re-injury prevention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Virginia Commonwealth University

Lead Sponsor

Trials
732
Recruited
22,900,000+

Centers for Disease Control and Prevention

Collaborator

Trials
902
Recruited
25,020,000+

Findings from Research

Out of 2,243 violently injured patients, 839 (37.4%) engaged with the Boston Violence Intervention Advocacy Program (VIAP), with younger age, Black race, and more severe injuries being significant predictors of engagement.
Clients who engaged with VIAP faced challenges in achieving goals related to education, employment, and housing, indicating that while the program is effective in reaching its target population, there is a need for tailored strategies to address these complex needs.
Boston Violence Intervention Advocacy Program: Challenges and Opportunities for Client Engagement and Goal Achievement.Pino, EC., Fontin, F., James, TL., et al.[2021]
Hospital-based violence intervention programs (HVIPs) aim to reduce future injuries by engaging individuals who have experienced violence, and a study involving 79 practitioners identified key outcomes like posttraumatic stress symptoms and emotional regulation that should be prioritized in assessing program effectiveness.
The findings suggest that measuring psychosocial health and well-being, alongside traditional outcomes like repeat violence, is crucial for a comprehensive understanding of recovery and can enhance the relevance of HVIP effectiveness studies.
Generating a Core Set of Outcomes for Hospital-Based Violence Intervention Programs.Monopoli, WJ., Myers, RK., Paskewich, BS., et al.[2021]
This study is part of a larger initiative involving 12 demonstration projects aimed at evaluating the effectiveness of hospital-based violence intervention programs (HBVIPs) through a randomized control trial with male victims of violence, comparing standard treatment to enhanced services over one year.
The primary goal is to assess whether enhanced services can significantly reduce trauma recidivism and improve mental health and quality of life, using robust statistical methods to analyze outcomes like death and recidivism.
Testing the efficacy of a hospital-based violence intervention programme: protocol and design.St Vil, C., Hall, EC., Sheppard, M., et al.[2022]

References

Boston Violence Intervention Advocacy Program: Challenges and Opportunities for Client Engagement and Goal Achievement. [2021]
Generating a Core Set of Outcomes for Hospital-Based Violence Intervention Programs. [2021]
Testing the efficacy of a hospital-based violence intervention programme: protocol and design. [2022]
Hospital-based violence intervention programs work. [2022]
What Is the Institutional Duty of Trauma Systems to Respond to Gun Violence? [2019]
Characteristics of Adult Patients for Violence-Related Injuries Presenting to a Level 1 Trauma Center in Midwest United States. [2023]
Cost-benefit analysis simulation of a hospital-based violence intervention program. [2017]
Operation CeaseFire-New Orleans: an infectious disease model for addressing community recidivism from penetrating trauma. [2014]
Assessing improvements in emergency department referrals to a hospital-based violence intervention program. [2021]